esophageal and head and neck cancers
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with malignant tumors clearly diagnosed by pathology or cytology; 2.ECOG score 0-2; 3. Age 18-80 years old; 4. Receiving radiotherapy and chemotherapy; 5. No obvious abnormality of liver and kidney function; 6. The patient is conscious, has no communication barriers, and can answer questions accurately; 7. Patients who sign informed consent and are willing to participate in this study;
Exclusion criteria
Exclusion criteria: 1. Uncontrolled or severe heart, liver, lung and kidney disease; 2. Patients with contraindicated enteral nutrition, such as severe diarrhea, vomiting, etc.; 3. Patients who have previously received radiotherapy for tumors at any site; 4. Patients who are allergic to product ingredients 5. Participating in other clinical investigators; 6. Those who do not want to participate in the study, or agree to participate but refuse to sign the informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nutrition Risk Screening 2002;Patient-generated Subjective Nutrition Assessment Score;Eastern Cooperative Oncology Group Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| albumin;hemoglobin;hematological parameters;radiotherapy complications; | — |
Countries
China
Contacts
Affiliated People's Hospital of Ningbo University